Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Lovir
Active Ingredient: Aciclovir 200mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturers: Ranbaxy Laboratories Limited, Himachal Pradesh, India
Ranbaxy Laboratories Limited, Madhya Pradesh, India
Product: Lovir
Active Ingredient: Aciclovir 400mg
Dosage Form: Dispersible Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturers: Ranbaxy Laboratories Limited, Himachal Pradesh, India
Ranbaxy Laboratories Limited, Madhya Pradesh, India
Product: Lovir
Active Ingredient: Aciclovir 800mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturers: Ranbaxy Laboratories Limited, Himachal Pradesh, India
Ranbaxy Laboratories Limited, Madhya Pradesh, India
Product: Panadol
Active Ingredient: Paracetamol 125mg
Dosage Form: Suppository
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer GlaxoSmithKline Australia Pty Limited, Ermington, Australia
Product: Panadol
Active Ingredient: Paracetamol 250mg
Dosage Form: Suppository
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer GlaxoSmithKline Australia Pty Limited, Ermington, Australia
Product: Panadol Children 3 months - 12 years
Active Ingredient: Paracetamol 24mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer GlaxoSmithKline Australia Pty Limited, Ermington, Australia
Dated this 11th day of April 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).